Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Marcia Ribeiro

Neurology Pikesville, MD Medical Doctor

NPI 1225087885 CMS profile 10465

1777 Reisterstown Rd, Suite 104, Pikesville, MD 21208

Open in the dashboard

General payments

$209,433

466 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Marcia Ribeiro of Pikesville, MD is reported in the CMS Open Payments database as having received $209,433 across 466 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $347 11
2022 General $3,263 3
2021 General $31,974 57
2020 General $83,434 183
2019 General $90,414 212

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marcia Ribeiro
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Marcia Ribeiro were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Marcia Ribeiro Neurology median Middle half National median
2019 $90,414 $474 $118–$2,177 $163
2020 $83,434 $367 $82–$2,309 $114
2021 $31,974 $438 $104–$2,547 $132
2022 $3,263 $442 $103–$2,388 $149
2023 $347 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Amgen Inc. $72,156 127 payments
  2. Lilly USA, LLC $45,908 98 payments
  3. Teva Pharmaceuticals USA, Inc. $41,091 85 payments
  4. Allergan Inc. $35,106 68 payments
  5. Biohaven Pharmaceuticals, Inc. $8,963 13 payments
  6. AbbVie, Inc. $3,647 16 payments
  7. Lundbeck LLC $1,710 2 payments
  8. Bausch Health US, LLC $402 45 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $113 1 payment
  10. Alexion Pharmaceuticals, Inc. $112 1 payment
  11. Other $224 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $172,643 118 payments
  2. Travel and Lodging $16,146 56 payments
  3. Consulting Fee $13,433 6 payments
  4. Food and Beverage $7,062 280 payments
  5. Education $108 5 payments
  6. Grant $42 1 payment
Products named General payments · program years 2019–2023
  1. AIMOVIG $72,156 127 payments
  2. UBRELVY Neuroscience $24,436 35 payments
  3. Ajovy Central Nervous System $22,053 42 payments
  4. REYVOW $19,350 25 payments
  5. AJOVY Central Nervous System $19,039 43 payments
  6. BOTOX $8,723 18 payments
  7. EMGALITY $7,795 19 payments
  8. UBRELVY Neuroscience $5,239 13 payments
  9. NURTEC ODT $4,576 13 payments
  10. VYEPTI $1,600 1 payment
  11. Other $1,381 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$591,294

Medicare's payments for the services billed

Medicare patients

370

Average age 69

Services billed

6,968

220 women, 150 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 46%
Diabetes 44%
Ischemic heart disease 24%
COPD 24%
Chronic kidney disease 22%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

466 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record